If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Which of the words do you not understand @Reality-fool? I know your total history of 4 spam messages does not bode well for a meaningful discussion, but hey nothing ventured nothing gained...
The point of the original post is that the company has access to plenty of funds and is well positioned with their recent expansion, to capitalise on the inevitable boom in this sector.
Its a side effect of the de-ramping dodo's that haunt this board
@Saricarrion, think statement below should allay your fears...
"As at 31 March 2020, the Company had full availability of the entire £20m RCF capacity. The RCF facility agreement also contains a trombone feature which, while not a firm additional facility commitment, enables a fast-track application for a further £20m extension of the RCF. Based on the Board's conservative internal analysis, it believes that the Company is highly unlikely to need the full £20m RCF to fund future activity, let alone the potential trombone extension.
In summary: the Board is confident that the Company's existing £20m RCF will be more than adequate to finance the business in the foreseeable future."
#saveCPI - I say!
Quite rightly today's rise can be attributed to shorters reducing positions, the drop over the last month and a half can be squarely placed at the door of shorters, the company has been improving significantly over the COVID period (winning contracts, cutting costs) yet share price dropping? that's market manipulation.
But the shorters are unlikely to leave entirely unless their positions become untenable, they will probably just drop below the .5% SSR Notification threshold and continue to manipulate - hopefully the #saveCine initiative will burn some of them - happy days
There is no way ODX are not engaged in the govt's "Dynamic Purchasing System" process for COVID tests already... only a matter of time before the news comes out on that.
The ABDX arrangement was just the tip of iceberg for ODX, it's COVID test manufacturing capacity will get used one way or another and the company will certainly benefit big time.
GLA
A little recap on why we're all here...
GDR already have the CE approval for 96 SARS-CoV-2 kit
- UK and European market accessible
In approval process with other regulators around the world
- South Africa now approved - market accessible
- US Approval - Emergency Use Authorisation (EUA) in progress with FDA
- Biden kickstarting the US battle against COVID (read deploying funds)
- India - Approval in progress
- POC System - looking like another best in class proposition
Company itself well funded
UK Govt alone pumping £43bn into Covid testing
- With 758mil already allocated to home testing
As other govts start launching initiatives like the US and UK the demand for tests will far outstrip supply.
The potential in this company is more than a little exceptional
GLA - DYOR
skid35, completely agree with you good business needs good financial management, and I think that will certainly increase at KMK with this opportunity.
With the scale of demand/growth available to KMK on the tech they're piloting, I don't think a lack of some optimisation in their financial management will delay realisation of the benefits.
This is one of those once in life time opportunities for a company - and for investors it's like finding Micro$oft when they were still operating out of Bill's garage - except KMK are exponentially further along...
Absolutely agree @SurreyCarrie - that tsunami of imminent insolvency prospects for MANO is going to reap massive rewards.
Only recently the company RNSed about how they had scaled up operations. That will stand them in good stead in the very very near future - when govt aid to unfortunate companies dries up.
Confirmed on ADVFN L2 - 2 massive 1.4mill each buys went through today after market close 16:35!
2021-01-26T16:34:07.910 GBX 195 750000 £1,462,500.00 Off-Book AIMX
2021-01-26T16:32:28.470 GBX 197.5 750000 £1,481,250.00 Off-Book AIMX
Someone is going heavy!
skid35, have a read of the article below - it addresses the points you raise and more...
https://www.investorschronicle.co.uk/comment/2020/10/07/tech-winner-in-fight-against-covid-19/
In this case the old warning "Past performance is no guarantee of future results" is exactly the correct statement but in REVERSE, past performance may have been sub par but the current strategy with the detection tech is a no-brainer, the demand for it is just too high, KMK literally cannot fail with it - all the hard work (development) is already done.
I’m thinking they’ll benefit hugely if they just hold the patents on the tech.
Seriously??!?! - OVEREACTION = CORRECTION straght after
What does everyone think is going to happen after the govt stops giving away free money?
As sad as it is, it's going to be boom time for MANO after March, this one is the best opp I've seen for a while.
Plus MANO has geared up to handle the increased business post COVID, ideally positioned to capitalise.
AROC contract doesn't seem to have been all that negative. Seems like a bit of a positive really, it's likely to turn up as nice little revenue credit pretty soon...
"Work in progress had been stockpiled for delivery and recognised as revenue over the course of the past 30 months. With shipment originally scheduled for 2020 onwards now delayed, the carrying value of accounts receivable under contract (AROC) is dependent on Kromek being able to prove a shipping date. It is unable to provide this at present, hence the £13.1m write-down to AROC in the accounts. However, all the stock remains on Kromek's balance sheet (and in its UK facilities) ready for shipment and delivery in the future, hence why the directors still expect the position to reverse, at which point Kromek can book a hefty exceptional credit. I am not sure investors have fully grasped this accounting point."
Source:
https://www.investorschronicle.co.uk/comment/2020/10/07/tech-winner-in-fight-against-covid-19/
What pressure can be greater than a world changing event such as COVID?
Think this will focus the company like never before.
The airborne detection proposal is a time critical venture and they're predicting deployment quite soon: "The Group expects the first pilots with potential users to commence by the end of this financial year and anticipates commercial deployment in 2021/22"
With the mainstream media (BBC) starting to cover the company and its efforts, only see more and more investors discovering the value here - seems inevitable that this stock will be unrecogizable in a very short space of time.
This is why GDR is going to rocket and all the deramping on this board will have 0 net effect.
https://hospitalhealthcare.com/covid-19/salvia-based-tests-as-accurate-as-nasopharyngeal-swabs-for-covid-19-diagnosis/
Earlier article for ref:
https://www.proactiveinvestors.co.uk/companies/news/932119/genedrive-plc-unveils-15-minute-covid-19-point-of-care-test-direct-from-saliva-932119.html
GDR will get some serious action, can deff see these tests being used in schools...
https://hospitalhealthcare.com/covid-19/salvia-based-tests-as-accurate-as-nasopharyngeal-swabs-for-covid-19-diagnosis/
Earlier article for ref:
https://www.proactiveinvestors.co.uk/companies/news/932119/genedrive-plc-unveils-15-minute-covid-19-point-of-care-test-direct-from-saliva-932119.html
Potential, potential is what it is - waiting until after that has been realised is a bit late in my book.
As far as good business goes getting funded by a government organisation is an excellent move!
When the govt sees results you can easily see stonking sums of money being thrown at this company.
Agree - they may need scaled infrastructure to capitalise and given COVID I don't think they'll have any probs securing that, the business of managing COVID is BIG just take a look at the testing sector.
This will not be the last pandemic - govts, businesses, organisations etc will all look to ways of mitigating the next occurrence, detection tech will be absolutely essential.
I'm seeing this tech as being as necessary as air conditioning units, the market for this is huge - the current rise is no where near its actual potential.
Sell on dudes, excellent opp to top up
Copper is king - given our insatiable need for tech, the copper prices are unlikely to retrace anytime soon - RMM ideally placed to capitalise